ADAR1 Capital Management, LLC bought $118k of INM
owner at InMed Pharmaceuticals Inc.. 91,101 shares at an average of $1.30, traded Sep 14, 2026, filed Sep 16, 2026.
Score components
- +12Role10% owner
- +10Trade size$118k at market
- +3Relative to holdingsHoldings up 11%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001940272-26-000021, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | POpen-market purchase Common Sharesindirect: See Footnote | +28,505 | $1.29 | $37k | 829,505 | 26 d ago |
| Sep 15, 2026 | POpen-market purchase Common Sharesindirect: See Footnote | +54,256 | $1.30 | $70k | 883,761 | 26 d ago |
| Sep 16, 2026 | POpen-market purchase Common Sharesindirect: See Footnote | +8,340 | $1.29 | $11k | 892,101 | 26 d ago |
Related signals
Other insiders at InMed Pharmaceuticals Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | INMbuy InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC owner | $14k 10,903 shares | +1% | |
| 19Weak | INMbuy InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC owner | $57k 42,920 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.